Re pricing, FWIW, there was talk earlier of GILD selling Sovaldi in Egypt for $900 per treatment, which begs the question of whether they can even do so, given that Solvaldi undoubtedly has not been trialed for HCV Genotype 4, which is prevalent in the Middle East.
Market Data 
Markets 
AI
